Elizabeth Homans

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Heather Turner, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Homans:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Executive Officer, Director Option (right to buy) 1,479,500 16 Mar 2022 Direct

Insider Reports Filed by Elizabeth Homans

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYEL Lyell Immunopharma, Inc. 16 Mar 2022 1 $0 4 Chief Executive Officer, Director 18 Mar 2022, 16:07
LYEL Lyell Immunopharma, Inc. 13 Sep 2021 1 $0 4 Chief Executive Officer, Director 14 Sep 2021, 16:17
LYEL Lyell Immunopharma, Inc. 16 Jun 2021 0 $0 3 Chief Executive Officer, Director 16 Jun 2021, 19:16